**7. Conclusions**

As somnambulism has not been recorded in non-human primates, no animal model exists to study somnambulism under controlled settings for elucidation of its biochemical mechanism of origin [90]. As such, the available pharmacological treatments have to be considered as the scatter-shot approach of case studies without *Somnambulism: Recent Findings DOI: http://dx.doi.org/10.5772/intechopen.102462*

appropriate controls [91]. Thus, partial or total alleviation of somnambulistic symptoms in children and adults deserves the attention of health researchers. Adequately powered, well-designed clinical trials remain the need of the moment. The plea made by Chinthapalli [92], an associate editor of the *British Medical Journal*, that medical schools should consider sleep medicine education seriously in their curriculum also deserves recognition.
